Fundz

Artbio Appoints Margaret Yu as Chief Medical Officer

PRIVATEJan 10, 2025

Position

Chief Medical Officer

Company

Artbio

Margaret Yu
margaret.yu@artbio.com
CambridgeBiotechnology

Description

Margaret Yu, with over 15 years of oncology drug development experience, has been named as the Chief Medical Officer at Artbio. In her new role, she will lead clinical development and regulatory strategies for innovative ARTs.

Quick answer

Artbio Appoints Margaret Yu as Chief Medical Officer (January 10, 2025). Artbio is based in Cambridge, Massachusetts, United States.

Who is the new Chief Medical Officer at Artbio?
Artbio named Margaret Yu Chief Medical Officer, announced January 10, 2025.
What did Artbio announce on January 10, 2025?
Margaret Yu, with over 15 years of oncology drug development experience, has been named as the Chief Medical Officer at Artbio. In her new role, she will lead clinical development and regulatory strategies for innovative ARTs.
What does Artbio do?
ARTBIO is a clinical-stage radiopharmaceutical company redefining cancer care by creating a new class of alpha radioligand therapies (ARTs).
Where is Artbio based?
Artbio is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Yaqrit (January 10, 2025), United Mitochondrial Disease Foundation (January 10, 2025), Chemify (January 10, 2025) and BIOTECanada (January 10, 2025) also announced leadership changes within 45 days of Artbio.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Artbio, and when

A new leader at Artbio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Artbio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Artbio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Artbio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Artbio

Location

Cambridge, Massachusetts, United States

About

ARTBIO is a clinical-stage radiopharmaceutical company redefining cancer care by creating a new class of alpha radioligand therapies (ARTs). The unique ARTBIO approach selects the optimal alpha-precursor isotope (212Pb) and tumor-specific targets to create therapeutics with the potential for highest efficacy and safety. The company's AlphaDirect™ technology, a first-of-its-kind 212Pb isolation method, enables a distributed manufacturing approach for the reliable production and delivery of ARTs. ARTBIO is advancing multiple pipeline programs with lead program AB001 in metastatic castration resistant prostate cancer currently in Phase 1 clinical trials. ARTBIO is shaped by a long-standing scientific legacy with nearly a century of pioneering work in radiation therapy conducted at the University of Oslo and Norway's Radium Hospital.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Artbio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Nick
Likely contact at this company
••••••••@••••••••

See Nick's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Artbio's next move

Learn about Strategic plan

Artbio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.